Overactive Bladder is a symptom syndrome characterised by urinary urgency, usually accompanied by increased daytime frequency and nocturia, with or without urgency urinary incontinence, in the absence of another condition that better explains the symptoms. Urgency is the defining symptom and refers to a sudden compelling desire to urinate that is difficult to defer. Overactive bladder is therefore not simply another name for urinary incontinence, because a person can have overactive bladder without leakage. It is also distinct from urinary tract infection, although infection can temporarily produce urgency and frequency. The diagnosis is fundamentally clinical and depends on the symptom pattern and exclusion of relevant alternative causes rather than requiring demonstration of involuntary bladder contractions on urodynamic testing.
The underlying physiology of overactive bladder is heterogeneous and can involve altered sensory processing, increased detrusor excitability, changes in bladder wall signalling, neurological regulation, and behavioural or environmental factors. Some individuals have demonstrable detrusor overactivity during urodynamic testing, but this is neither necessary nor sufficient to define the clinical syndrome. Bladder sensation can become heightened so that normal filling produces urgency earlier than expected, while involuntary detrusor contractions can contribute to leakage.
Neurological conditions affecting central or peripheral control can cause bladder overactivity, but many patients have no single identifiable structural cause. Age-related changes, pelvic-floor dysfunction, urinary infection, constipation, excessive fluid or caffeine intake, and certain medications can influence urinary symptoms and must be considered when evaluating the presentation.
The core symptom is urgency, often accompanied by frequent daytime urination and waking at night to void. Urgency urinary incontinence may occur when the individual cannot reach the toilet before involuntary leakage. Symptoms can interfere substantially with sleep, work, travel, exercise, social activities, and concentration. Patients may develop behavioural adaptations such as locating toilets in advance, limiting fluids, voiding pre-emptively, or avoiding situations where bathroom access is uncertain.
These adaptations can sometimes reinforce urinary frequency by conditioning the bladder to empty at relatively small volumes. Nocturia has many causes beyond overactive bladder, including excessive nighttime urine production, sleep disorders, fluid redistribution, and other medical conditions, so nocturia alone should not automatically be attributed to bladder overactivity.
Assessment involves establishing the symptom pattern and looking for alternative explanations. A bladder diary can record voiding frequency, urine volumes, urgency, leakage, fluid intake, and nocturnal patterns and can be especially useful in distinguishing bladder storage problems from excessive urine production. Urinalysis can help exclude infection, haematuria, and other urinary abnormalities. Post-void residual measurement may be appropriate when incomplete emptying or retention is suspected.
Urodynamic testing is generally reserved for selected cases where the diagnosis is uncertain, symptoms are complex, neurological disease is present, or invasive treatment is being considered. Imaging and cystoscopy are not routinely required for uncomplicated symptoms but may be indicated when there are warning features or another urological disorder is suspected.
First-line management commonly includes behavioural and lifestyle interventions. Bladder training can gradually increase the interval between voids and improve the ability to defer urgency. Pelvic-floor muscle training can help some individuals, particularly when urgency and urgency incontinence coexist. Adjusting excessive fluid intake and reducing substantial caffeine or other bladder irritants may improve symptoms in selected patients, although indiscriminate fluid restriction is not advisable. Constipation should be addressed because bowel distension can influence bladder function. When conservative measures are insufficient, pharmacological options include antimuscarinic medicines and beta-3 adrenergic receptor agonists, each with different adverse-effect profiles and contraindications. Treatment should be individualised and reviewed because persistence, tolerability, adherence, and interactions with other conditions affect long-term success.
Advanced treatment can be considered when symptoms remain troublesome despite conservative and medication-based management. Options may include intradetrusor botulinum toxin injections, which reduce detrusor activity but can increase the risk of urinary retention and urinary tract infection, or neuromodulation approaches that alter neural control of bladder function. The suitability of these treatments depends on the individual's symptoms, previous treatments, comorbidities, ability to manage possible catheterisation, and specialist assessment. Treatment does not necessarily eliminate all urgency because the syndrome can arise from multiple interacting mechanisms. Long-term management may require combining behavioural strategies with medication or procedural treatment and periodically reassessing whether the original diagnosis remains appropriate.
Overactive bladder can be distinguished from several superficially similar conditions. Urinary tract infection generally requires evidence supporting infection and may cause acute dysuria or systemic symptoms, whereas chronic overactive bladder symptoms can occur without infection. Stress incontinence is leakage triggered by increased abdominal pressure rather than urgency, although stress and urgency symptoms can coexist.
Urinary retention is fundamentally a failure to empty rather than a primary storage syndrome, although some patients with retention may experience frequency or urgency from an incompletely emptied bladder. Polyuria means an abnormally high volume of urine production and can cause frequent urination without a primary bladder-storage disorder. These distinctions are clinically important because treating presumed overactive bladder without recognising infection, obstruction, excessive urine production, or neurological disease can delay appropriate treatment.
A common misconception is that overactive bladder means the bladder is physically enlarged or structurally abnormal. The term describes a symptom syndrome and does not necessarily imply a specific anatomical lesion. Another misconception is that urgency always indicates infection; persistent or recurrent urgency with negative testing requires consideration of other causes. Overactive bladder also does not mean that a person must have urinary leakage, because urgency can occur without incontinence.
The condition is common but should not simply be accepted as unavoidable ageing, especially when symptoms interfere with quality of life. Effective management often requires identifying individual triggers and mechanisms rather than relying on a single treatment, and persistent atypical symptoms should prompt reconsideration of the diagnosis.
